Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience - Joshua P Havens; Jennifer O'Neill; Maureen Kubat; Jennifer M Davis; Nada Fadul; Shawnalyn W Sunagawa; Sara H Bares (Clinical Infectious Diseases, 2026)